Article · 29 Aug 2026
Research articlePublished 2017
Development of an in vitro Biochemical Assay System for the Measurement of Residual Toxin Activities in Pertussis Toxin Containing Vaccines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pertussis (whooping cough) vaccines play an essential role in immunisation programmes worldwide and the histamine sensitisation test (HIST) is currently the official batch-release test for acellular pertussis containing combination vaccines. HIST, being a murine animal test, has large assay variability problems and ethical issues. Therefore, in response to the 3Rs, a biochemical assay system has been developed based on the pertussis toxin (PTx)’s two functional domains: an enzyme active A-protomer and a carbohydrate binding B-oligomer. The clinical relevance of these two biochemical tests in relation to the PTx toxic effects has been demonstrated. In order to assess the practicality of this assay system, an international collaborative study involving 9 countries on method transferability had also been performed and showed that this assay system could be adopted readily in control laboratories and vaccine manufacturing facilities. In this update, we provide further optimised assay conditions for measuring both the residual PTx ADP-ribosyltransferase and carbohydrate binding activities in specific vaccines. In general, appropriate dilution of vaccines would help to increase test sensitivity. Spiking experiments showed carbohydrate binding assay could detect low levels of PTx similar to HIST. Although positive trend with increasing spikes could also be demonstrated in ADP-ribosyltransferase activity assay for some vaccines, the resultant values in a number of spiked vaccines were not statistically significant and this is due to high baseline activity of the unspiked vaccines. Since all the reagents of this biochemical assay system are available worldwide, readily controlled and with good test consistency, both assays could be used for monitoring product consistency. The carbohydrate binding assay could even be considered as a potential alternative to HIST for batch-release of acellular pertussis vaccines. Protocols for this in vitro assay system are supplied as Supplement Documents 1 & 2.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Chun-Ting Yuen”
- BylineArticles whose byline prints “Catpagavalli Asokanathan”
- BylineArticles whose byline prints “Alexandra Douglas-Bardsley”
- BylineArticles whose byline prints “Kevin Markey”
- BylineArticles whose byline prints “Peter Rigsby”
- BylineArticles whose byline prints “Dorothy Xing”